Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1936 AL 1950

Impact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer's disease

Sprugnoli G, Munsch F, Cappon D, Paciorek R, Macone J, Connor A, El Fakhri G, Salvador R, Ruffini G, Donohoe K, Shafi MM, Press D, Alsop DC, Pascual Leone A, Santarnecchi E.

Alzheimers Res Ther. 2021 Dec 20;13(1):203. doi: 10.1186/s13195-021-00922-4.

Vascular Cognitive Impairment (VCI)

Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ.

Neurotherapeutics. 2022 Jan;19(1):68-88. doi: 10.1007/s13311-021-01170-y. Epub 2021 Dec 22.

Agreement Between Automated and Manual MRI Volumetry in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Quek YE, Fung YL, Cheung MW, Vogrin SJ, Collins SJ, Bowden SC.

J Magn Reson Imaging. 2022 Aug;56(2):490-507. doi: 10.1002/jmri.28037. Epub 2021 Dec 29.

Preliminary analysis of a shortened picture version of the Free and Cued Selective Reminding Test

Rodrigo-Herrero S, Mendez-Barrio C, Bernal Sánchez-Arjona M, de Miguel-Tristancho M, Graciani-Cantisán E, Carnero-Pardo C, Franco-Macías E.

Neurologia (Engl Ed). 2022 Apr;37(3):192-198. doi: 10.1016/j.nrleng.2018.12.019. Epub 2021 Feb 26.

Recent Advancements in Electrochemical Biosensors for Alzheimer's Disease Biomarkers Detection

Mikuła E.

Curr Med Chem. 2021;28(20):4049-4073. doi: 10.2174/0929867327666201111141341.

Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers

Gopalan D, Pandey A, Alex AT, Kalthur G, Pandey S, Udupa N, Mutalik S.

Nanotechnology. 2021 Apr 2;32(14):142002. doi: 10.1088/1361-6528/abcdcb.

A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease

Bouftas M.

J Prev Alzheimers Dis. 2021;8(1):84-91. doi: 10.14283/jpad.2020.57.

Dementia research in 2020: moving forward despite the COVID-19 pandemic

Kivipelto M, Mangialasche F.

Lancet Neurol. 2021 Jan;20(1):3-5. doi: 10.1016/S1474-4422(20)30453-1.

Brain changes associated with sleep disruption in cognitively unimpaired older adults: A short review of neuroimaging studies

André C, Laniepce A, Chételat G, Rauchs G.

Ageing Res Rev. 2021 Mar;66:101252. doi: 10.1016/j.arr.2020.101252. Epub 2021 Jan 5.

Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans

Moon S, Kim S, Mankhong S, Choi SH, Vandijck M, Kostanjevecki V, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Kim HJ, Jang JW, Hong JY, Park DH, Shaw LM, Kang JH.

Alzheimers Res Ther. 2021 Jan 12;13(1):22. doi: 10.1186/s13195-020-00767-3.

Polyamine biomarkers as indicators of human disease

Amin M, Tang S, Shalamanova L, Taylor RL, Wylie S, Abdullah BM, Whitehead KA.

Biomarkers. 2021 Mar;26(2):77-94. doi: 10.1080/1354750X.2021.1875506. Epub 2021 Jan 25.

Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series

James OG, Linares AR, Hellegers C, Doraiswamy PM, Wong TZ.

Clin Nucl Med. 2021 Jul 1;46(7):605-608. doi: 10.1097/RLU.0000000000003493.

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.

JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.

Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease

Leuzy A, Cullen NC, Mattsson-Carlgren N, Hansson O.

Curr Opin Neurol. 2021 Apr 1;34(2):266-274. doi: 10.1097/WCO.0000000000000904.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias